Regístrese
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Exhaled nitric oxide in relation to asthma control: A real-life survey
Información de la revista
Vol. 44. Núm. 3.
Páginas 197-205 (Mayo - Junio 2016)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
ePub
Vol. 44. Núm. 3.
Páginas 197-205 (Mayo - Junio 2016)
Original Article
DOI: 10.1016/j.aller.2015.05.012
Exhaled nitric oxide in relation to asthma control: A real-life survey
Visitas
187
F.L.M. Ricciardoloa, V. Sorbelloa, R. Bellezza Fontanaa, I. Schiavettib, G. Ciprandic,
Autor para correspondencia
gio.cip@libero.it

Corresponding author.
a Department of Clinical and Biological Sciences, University of Torino, Turin, Italy
b Department of Health, University of Genoa, Genoa, Italy
c Department of Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino, Genoa, Italy
Este artículo ha recibido
187
Visitas
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (4)
Mostrar másMostrar menos
Tablas (2)
Table 1. Baseline characteristics (N=363).
Table 2. Statistically significant associations between FeNO and clinical and medical history variables.
Mostrar másMostrar menos
Abstract
Background

Asthma is characterised by chronic airway inflammation, a complex cascade of events, mostly sustained by eosinophil recruitment and activation. Fractional exhaled nitric oxide (FeNO) is a surrogate marker of airway inflammation closely associated with bronchial eosinophilia. FeNO is used to define asthma phenotype, to assess eosinophilic inflammatory severity and to predict corticosteroid responsiveness.

Objective

The aim of this study was to investigate whether FeNO may be associated with some clinical and functional factors in asthmatics evaluated in a real life setting.

Methods

Globally 363 patients (150 males, mean age 46.3 years) with asthma were consecutively evaluated. The following parameters were assessed: history, including comorbidities, physical examination, body mass index (BMI), lung function, asthma control grade, asthma control test (ACT), and FeNO.

Results

FeNO values were significantly higher in patients with poorly controlled asthma (p<0.01), asthma symptoms (p=0.015), wheezing (p<0.001), rhinitis diagnosis, (p=0.049) and rhinitis symptoms (p=0.019), but lower in patients with GERD (p=0.024) and pneumonia history (p=0.048). FeNO values increased in patients with the lowest corticosteroid dose (p=0.031). FeNO values>25ppb were associated with poorly controlled asthma (OR 3.71), asthma signs (OR 3.5) and symptoms (OR 1.79). A FeNO value cut-off of 29.9ppb was fairly predictive of (AUC 0.7) poorly controlled asthma.

Conclusions

FeNO assessment in clinical practice may be a useful tool for monitoring asthmatics as it is associated with several clinical factors, including asthma control.

Keywords:
Asthma
Exhaled nitric oxide
Asthma control
Rhinitis
Asthma control test
Abbreviations:
ACT
BHR
FeNO
FEF25–75
FEV1
FVC
ICS

Artículo

Opciones para acceder a los textos completos de la publicación Allergologia et Immunopathologia
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Suscribirse
Suscribirse a:

Allergologia et Immunopathologia

Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.